Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 8/20 | 1.00 |
| ▸ | CYP1A2 | P05177 | 1/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 1/20 | 1.00 |
| ▸ | CYP2D6 | P10635 | 1/20 | 1.00 |
| ▸ | CYP2C9 | P11712 | 1/20 | 1.00 |
| ▸ | CYP2C19 | P33261 | 1/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.97 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.88 |
| ▸ | TSHR | P16473 | 4/20 | 0.82 |
| ▸ | RECQL | P46063 | 2/20 | 0.82 |
| ▸ | MAPT | P10636 | 2/20 | 0.71 |
| ▸ | NPC1 | O15118 | 1/20 | 0.71 |
| ▸ | PKM | P14618 | 1/20 | 0.71 |
| ▸ | RAB9A | P51151 | 1/20 | 0.71 |
| ▸ | MAOB | P27338 | 2/20 | 0.69 |
| ▸ | GAA | P10253 | 1/20 | 0.66 |
| ▸ | GFER | P55789 | 1/20 | 0.66 |
| ▸ | LMNA | P02545 | 1/20 | 0.63 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.63 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13486221 | 1.00 | HPGD (1.00) | HPGDCYP1A2CYP3A4CYP2D6CYP2C9 | |
| SCHEMBL14140751 | 1.00 | HPGD (1.00) | HPGDCYP1A2CYP3A4CYP2D6CYP2C9 | |
| SCHEMBL5970063 | 0.98 | HPGD (1.00) | HPGDCYP1A2CYP3A4CYP2D6CYP2C9 | |
| SCHEMBL108225 | 0.92 | ALDH1A1 (0.90) | HPGDCYP1A2CYP3A4CYP2D6CYP2C9 | |
| SCHEMBL244490 | 0.90 | HPGD (1.00) | HPGDCYP1A2CYP3A4CYP2D6CYP2C9 | |
| SCHEMBL7464300 | 0.84 | HPGD (0.75) | HPGDCYP1A2CYP3A4CYP2D6CYP2C9 | |
| SCHEMBL7433458 | 0.84 | HPGD (0.75) | HPGDCYP1A2CYP3A4CYP2D6CYP2C9 | |
| SCHEMBL8475795 | 0.83 | HPGD (0.71) | HPGDCYP1A2CYP3A4CYP2D6CYP2C9 | |
| SCHEMBL93930 | 0.83 | ALDH1A1 (0.76) | HPGDCYP1A2CYP3A4CYP2D6CYP2C9 | |
| SCHEMBL23675311 | 0.83 | HPGD (0.69) | HPGDCYP1A2CYP3A4CYP2D6CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 137 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115721652-B | Application of Securinega suffruticosa alkali or derivative thereof | 赣南医学院 | 2024-03-08 | — | — | CN | claimed |
| CN-114178612-B | Novel board sawing machine | 浙江锯力煌工业科技股份有限公司 | 2023-09-08 | — | — | CN | claimed |
| CN-114540534-B | Moso bamboo oligonucleotide probe | 浙江农林大学 | 2023-08-25 | — | — | CN | claimed |
| CN-114540348-B | Moso bamboo oligonucleotide probe | 浙江农林大学 | 2023-06-30 | — | — | CN | claimed |
| CN-115721652-A | Application of securinine or derivatives thereof | 赣南医学院 | 2023-03-03 | — | — | CN | claimed |
| US-20230010108-A1 | A CONJUGATION LINKER CONTAINING 2,3-DIAMINOSUCCINYL GROUP | HANGZHOU DAC BIOTECH CO., LTD. (CN) | 2023-01-12 | — | — | US | claimed |
| CN-114540348-A | Phyllostachys pubescens oligonucleotide probe | 浙江农林大学 | 2022-05-27 | — | — | CN | claimed |
| CN-114540534-A | Mao bamboo oligonucleotide probe | 浙江农林大学 | 2022-05-27 | — | — | CN | claimed |
| CN-112980833-B | Phyllostachys pubescens oligonucleotide probe and obtaining method and using method thereof | 浙江农林大学 | 2022-05-06 | — | — | CN | claimed |
| US-20160257957-A1 | METHODS AND COMPOSITIONS FOR TREATMENT OF ANGELMAN SYNDROME AND AUTISM SPECTRUM DISORDERS | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2016-09-08 | — | — | US | claimed |
| US-20130058915-A1 | METHODS AND COMPOSITIONS FOR TREATMENT OF ANGELMAN SYNDROME AND AUTISM SPECTRUM DISORDERS | Children's Medica Center Corporation (US) | 2013-03-07 | — | — | US | claimed |
| EP-2544688-A2 | METHODS AND COMPOSITIONS FOR TREATMENT OF ANGELMAN SYNDROME AND AUTISM SPECTRUM DISORDERS | President and Fellows of Harvard College (US) | 2013-01-16 | — | — | EP | claimed |
| WO-2011109398-A2 | METHODS AND COMPOSITIONS FOR TREATMENT OF ANGELMAN SYNDROME AND AUTISM SPECTRUM DISORDERS | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2011-09-09 | — | — | WO | claimed |
| WO-2006034196-A1 | COMPOSITIONS FOR ENHANCING MEMORY AND METHODS THEREFOR | LIFELIKE BIOMATIC INC. (US) | 2006-03-30 | — | — | WO | claimed |
| US-20060063707-A1 | Compositions for enhancing memory and methods therefor | LIFELIKE BIOMATIC, INC. (US) | 2006-03-23 | — | — | US | claimed |
| US-20250388685-A1 | METHODS FOR TREATING CHRONIC RHINOSINUSITIS WITHOUT NASAL POLYPS BY ADMINISTERING AN IL-4R ANTAGONIST | SANOFI BIOTECHNOLOGY (FR) | 2025-12-25 | — | — | US | disclosed |
| EP-4638436-A1 | PRMT5 INHIBITORS AND USES THEREOF | GILEAD SCIENCES, INC. (US) | 2025-10-29 | — | — | EP | disclosed |
| WO-1997034878-A1 | SUBSTITUTED 2,3-BENZODIAZEPIN-4-ONES AND THE USE THEREOF | COCENSYS, INC. (US) | 1997-09-25 | — | — | WO | disclosed |
| EP-0651746-A1 | DRUGS THAT ENHANCE SYNAPTIC RESPONSES MEDIATED BY AMPA RECEPTORS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1995-05-10 | — | — | EP | disclosed |
| WO-1994002475-A1 | DRUGS THAT ENHANCE SYNAPTIC RESPONSES MEDIATED BY AMPA RECEPTORS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1994-02-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060063707-A1 | Compositions for enhancing memory and methods therefor | GRIN1, GRIN3A, GRIN2A | HPGD 1202/4885CYP1A2 4871/4885CYP3A4 4785/4885 |
| US-20230010108-A1 | A CONJUGATION LINKER CONTAINING 2,3-DIAMINOSUCCINYL GROUP | DAO, DDO, DCLRE1A | HPGD 877/4885CYP1A2 1441/4885CYP3A4 2182/4885 |
| US-20250388685-A1 | METHODS FOR TREATING CHRONIC RHINOSINUSITIS WITHOUT NASAL POLYPS BY ADMINISTERING AN IL-4R ANTAGONIST | IL4, CCR4, IL1RN | HPGD 1358/4885CYP1A2 796/4885CYP3A4 119/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.